Deborah Long,Jessica Flechtner,Mojca Skoberne,George R. Siber
申请号：
US15860742
公开号：
US20180369365A1
申请日:
2018.01.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
